Members of the Mexican cannabis sector have told CannIntelligence they are pessimistic about whether the framework to regulate the national medical cannabis industry will be implemented before 2024.

This is despite the presentation of a draft last year by the Health Ministry and the Federal Commission for the Protection Against Health Risks (Cofepris), and the 2017 congressional legalisation of medical cannabis for therapeutic uses.

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

VIEW REPORTS

Request a free sample of this report:

“ Grey area over medical cannabis regime in Mexico leaves industry pessimistic ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ Grey area over medical cannabis regime in Mexico leaves industry pessimistic ”






      Members of the Mexican cannabis sector have told CannIntelligence they are pessimistic about whether the framework to regulate the national medical cannabis industry will be implemented before 2024.

      This is despite the presentation of a draft last year by the Health Ministry and the Federal Commission for the Protection Against Health Risks (Cofepris), and the 2017 congressional legalisation of medical cannabis for therapeutic uses.

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik